West Pharmaceutical Services (WST)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 299 |
| % of all portfolios: | 0.028% |
| Hold Price * : | $250.63 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q4 2025 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Sell 100.00% | 1,172,583 | 2.28 | |
| ≡ | Hillman Capital Management | Reduce 13.31% | 1,367 | 0.24 | |
| Q2 2025 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Reduce 33.85% | 532,471 | 0.88 | |
| Q4 2024 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Reduce 41.30% | 448,521 | 1.20 | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 994 | 0.01 | |
| Q1 2024 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Reduce 9.46% | 107,677 | 0.33 | |
| Q4 2023 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Reduce 5.27% | 63,339 | 0.18 | |
| Q3 2023 | |||||
| ≡ | Henry Ellenbogen - Durable Capital Partners | Reduce 5.98% | 76,506 | 0.26 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 1,645 | 0.01 | |
| Q2 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 98,230 | 0.14 | |
| Q1 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 1.72% | 1,720 | 0.00 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.